福瑞股份：内蒙古证监局对公司采取责令改正措施

Core Viewpoint - The company, Furuya Co., Ltd. (300049.SZ), has received a decision from the Inner Mongolia Regulatory Bureau of the China Securities Regulatory Commission, indicating several compliance issues related to internal controls and revenue recognition practices [1][2]. Group 1: Internal Control Issues - The company has inadequate internal control management over its overseas subsidiaries, lacking established risk management systems and supervision mechanisms, which violates the Corporate Governance Guidelines [1]. Group 2: Revenue Recognition Issues - The company has recognized revenue prematurely, with specific amounts of 240.89 thousand, 288.10 thousand, 567.03 thousand, and 134.17 thousand for the semi-annual and annual reports of 2023 and 2024, affecting the accuracy of financial disclosures [2]. - A specific instance in June 2023 involved the full recognition of revenue for a drug sale with a return clause, which was not properly accounted for when the product was returned in August, leading to inaccuracies in the semi-annual report [2]. - The company failed to reasonably estimate variable consideration such as sales discounts and rebates in its accounting for 2023 and 2024, resulting in full revenue recognition without appropriate adjustments [2].